or
forgot password

    • cancer clinical trials in kalamazoo, MI

    • S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Bronson Methodist Hospital

    Trial Locations
    Bronson Methodist Hospital
    West Michigan Cancer Center
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    West Michigan Cancer Center
    Kalamazoo, Michigan 49007-3731
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Kalamazoo, Michigan 49048
    Rheumatoid Arthritis
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Bronson Methodist Hospital

    Trial Locations
    Bronson Methodist Hospital
    West Michigan Cancer Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer
    West Michigan Cancer Center
    Kalamazoo, Michigan 49007-3731
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Bronson Methodist Hospital

    Trial Locations
    Bronson Methodist Hospital
    West Michigan Cancer Center
    Light Chain Deposition Disease, Primary Systemic Amyloidosis
    Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Kalamazoo, Michigan 49048
    Non Small Cell Lung Cancer
    A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer
    West Michigan Cancer Center
    Kalamazoo, Michigan 49007-3731
    Metastatic Pancreatic Cancer
    Safety Study of ExAblate for the Treatment of Uterine Fibroids
    Borgess Research Institute
    Kalamazoo, Michigan 49048
    Uterine Fibroids
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Bronson Methodist Hospital

    Trial Locations
    Bronson Methodist Hospital
    West Michigan Cancer Center
    Colorectal Cancer, Metastatic Cancer
    BIBF 1120 in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Bronson Methodist Hospital

    Trial Locations
    Bronson Methodist Hospital
    West Michigan Cancer Center
    Endometrial Cancer
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    West Michigan Cancer Center
    Kalamazoo, Michigan 49007-3731
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer